176 related articles for article (PubMed ID: 16406210)
1. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury.
Ozdemir R; Parlakpinar H; Polat A; Colak C; Ermis N; Acet A
Toxicology; 2006 Feb; 219(1-3):142-9. PubMed ID: 16406210
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: a hemodynamic, biochemical, histopathological and electron microscopic evidence.
Goyal SN; Bharti S; Arora S; Golechha M; Arya DS
Biomed Pharmacother; 2010 Nov; 64(9):639-46. PubMed ID: 20888175
[TBL] [Abstract][Full Text] [Related]
3. Protection from renal ischemia reperfusion injury by an endothelin-A receptor antagonist BQ-123 in relation to nitric oxide production.
Erdogan H; Fadillioglu E; Emre MH
Toxicology; 2006 Dec; 228(2-3):219-28. PubMed ID: 17046139
[TBL] [Abstract][Full Text] [Related]
4. Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
Gupta SK; Saxena A; Singh U; Arya DS
Mol Cell Biochem; 2005 Jul; 275(1-2):67-74. PubMed ID: 16335785
[TBL] [Abstract][Full Text] [Related]
5. Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction.
Azizi Y; Faghihi M; Imani A; Roghani M; Nazari A
Peptides; 2013 Aug; 46():76-82. PubMed ID: 23727032
[TBL] [Abstract][Full Text] [Related]
6. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
[TBL] [Abstract][Full Text] [Related]
7. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
McMurdo L; Thiemermann C; Vane JR
Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes.
Sahna E; Parlakpinar H; Turkoz Y; Acet A
Physiol Res; 2005; 54(5):491-5. PubMed ID: 15641932
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment.
Gupta SK; Mohanty I; Talwar KK; Dinda A; Joshi S; Bansal P; Saxena A; Arya DS
Mol Cell Biochem; 2004 May; 260(1-2):39-47. PubMed ID: 15228084
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
Singh AD; Amit S; Kumar OS; Rajan M; Mukesh N
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):604-10. PubMed ID: 16700825
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart.
Bugge E; Ytrehus K
Cardiovasc Res; 1996 Nov; 32(5):920-9. PubMed ID: 8944823
[TBL] [Abstract][Full Text] [Related]
12. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog.
Krause SM; Lynch JJ; Stabilito II; Woltmann RF
Cardiovasc Res; 1994 Nov; 28(11):1672-8. PubMed ID: 7842461
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.
Watanabe T; Awane Y; Ikeda S; Fujiwara S; Kubo K; Kikuchi T; Kusumoto K; Wakimasu M; Fujino M
Br J Pharmacol; 1995 Mar; 114(5):949-54. PubMed ID: 7780649
[TBL] [Abstract][Full Text] [Related]
15. Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.
Wang X; Cheng Y; Xue H; Yue Y; Zhang W; Li X
Fitoterapia; 2015 Sep; 105():16-25. PubMed ID: 26025856
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effect of tetrahydrocurcumin and rutin on lipid peroxides and antioxidants in experimentally induced myocardial infarction in rats.
Ali MS; Mudagal MP; Goli D
Pharmazie; 2009 Feb; 64(2):132-6. PubMed ID: 19320287
[TBL] [Abstract][Full Text] [Related]
17. BQ-123, a specific endothelin (ETA) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation.
Büyükgebiz O; Aktan AO; Haklar G; Yalçin AS; Yeğen C; Yalin R; Ercan ZS
Transpl Int; 1996; 9(3):201-7. PubMed ID: 8723187
[TBL] [Abstract][Full Text] [Related]
18. The novel non-peptide selective endothelin A receptor antagonist LU 135,252 protects against myocardial ischaemic and reperfusion injury in the pig.
Gonon AT; Wang QD; Shimizu M; Pernow J
Acta Physiol Scand; 1998 Jun; 163(2):131-7. PubMed ID: 9648631
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
Wang QD; Li XS; Lundberg JM; Pernow J
Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
[TBL] [Abstract][Full Text] [Related]
20. Reduction of ischemia--reperfusion induced myocardial infarct size in rats by caffeic acid phenethyl ester (CAPE).
Ozer MK; Parlakpinar H; Acet A
Clin Biochem; 2004 Aug; 37(8):702-5. PubMed ID: 15302615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
